Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9308584rdf:typepubmed:Citationlld:pubmed
pubmed-article:9308584lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0032611lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0677582lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0002996lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0175566lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0729665lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0445202lld:lifeskim
pubmed-article:9308584lifeskim:mentionsumls-concept:C0355642lld:lifeskim
pubmed-article:9308584pubmed:issue3lld:pubmed
pubmed-article:9308584pubmed:dateCreated1997-10-22lld:pubmed
pubmed-article:9308584pubmed:abstractTextMaintenance of hemodialysis access grafts represents an enormous social and clinical problem. Current grafts and graft salvage techniques are inadequate. Consequently, there has been increasing interest in the use of minimally invasive catheter techniques to prophylactically treat stenoses in functioning arteriovenous grafts. Prophylactic balloon angioplasty has been widely suggested as prolonging assisted primary patency. We have performed a prospective randomized trial to compare patients who underwent percutaneous transluminal angioplasty (PTA) for graft stenoses > 50% with a control group that received no intervention. Our hypothesis was that to be efficacious a minimal benefit of 20% prolongation in patency would be necessary.lld:pubmed
pubmed-article:9308584pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9308584pubmed:languageenglld:pubmed
pubmed-article:9308584pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9308584pubmed:citationSubsetIMlld:pubmed
pubmed-article:9308584pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9308584pubmed:statusMEDLINElld:pubmed
pubmed-article:9308584pubmed:monthSeplld:pubmed
pubmed-article:9308584pubmed:issn0741-5214lld:pubmed
pubmed-article:9308584pubmed:authorpubmed-author:HarkerL ALAlld:pubmed
pubmed-article:9308584pubmed:authorpubmed-author:MacDonaldM...lld:pubmed
pubmed-article:9308584pubmed:authorpubmed-author:MartinL GLGlld:pubmed
pubmed-article:9308584pubmed:authorpubmed-author:CotsonisG AGAlld:pubmed
pubmed-article:9308584pubmed:authorpubmed-author:KikeriDDlld:pubmed
pubmed-article:9308584pubmed:authorpubmed-author:LumsdenA BABlld:pubmed
pubmed-article:9308584pubmed:issnTypePrintlld:pubmed
pubmed-article:9308584pubmed:volume26lld:pubmed
pubmed-article:9308584pubmed:ownerNLMlld:pubmed
pubmed-article:9308584pubmed:authorsCompleteYlld:pubmed
pubmed-article:9308584pubmed:pagination382-90; discussion 390-2lld:pubmed
pubmed-article:9308584pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:meshHeadingpubmed-meshheading:9308584-...lld:pubmed
pubmed-article:9308584pubmed:year1997lld:pubmed
pubmed-article:9308584pubmed:articleTitleProphylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study.lld:pubmed
pubmed-article:9308584pubmed:affiliationDepartment of Surgery, Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA, USA.lld:pubmed
pubmed-article:9308584pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9308584pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9308584pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9308584pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9308584pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9308584lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9308584lld:pubmed